Pfizer's 7% yield and forward P/E of 8 complement Viatris's three FDA PDUFA decisions arriving before year-end 2026. Kimberly-Clark's pending acquisition of Kenvue at $3.50 cash plus shares gives ...
The Ravens crack the top five in ESPN’s starting lineup rankings. Kyle Hamilton and Malaki Starks are No. 2 in safety duo ...
Former point guard closes the book on remarkable 20-year NBA career by fulfilling his long-time promise to sign a one-day ...
18h
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
21h
Natixis Investment Managers and Loomis Sayles Collaborate on Launch of Two Active Fixed Income ETFs
Loomis, Sayles & Company, an affiliate of Natixis Investment Managers with nearly $418 billion in assets under management*, today announced the launch of two actively managed fixed income ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...
Orbital Compute Inc. has filed with US regulators to launch hundreds of thousands of satellites in the coming years. “Global ...
Cycle Holdings Corp. (NYSE: LICY) ("Li-Cycle" or the "Company"), a leading global lithium-ion battery resource recovery company, today announced financial results for ...
Brendan Byrnes is the Managing Director at Motley Fool Money, where he leads business strategy and editorial operations. Since joining The Motley Fool in 2011, he has written hundreds of articles, ...
MFA Financial Series B preferred offers a ~9.25% yield, trade at a considerable discount to par, appealing to income-oriented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results